The Effect of Hippotherapy Simulator in Children with Spastic Cerebral Palsy
NCT ID: NCT06404827
Last Updated: 2025-01-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
26 participants
INTERVENTIONAL
2024-02-20
2024-11-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study aims to research the potential benefits of the horseback riding simulator on the lower extremity selective motor control, balance and trunk control in children with Cerebral palsy.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hippotherapy Simulators on Trunk Control and Upper Extremity Functions in Cerebral Palsy
NCT06554171
Investigation of the Effect of Hippotherapy Simulator in Children With Spastic Diplegia and Cerebral Palsy
NCT06003868
The Effect of Hippotherapy Simulator in Cerebral Palsy
NCT05518370
Hippotherapy Simulator in Children With Cerebral Palsy
NCT04378036
Effectiveness of Hippotherapy Simulator in PwMS
NCT04651725
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Intervention group: horseback riding simulator (HRS) will be applied in addition to routine Physiotherapy and Rehabilitation. This group will receive 20 minutes of routine physiotherapy training and 20 minutes of HRS application in addition to 2 sessions per week for 8 weeks.
Control group: Routine physiotherapy training will be applied within a specific programme for 40 minutes in 2 sessions per week for 8 weeks.
All the assessments will be performed before and after the training in the 8-week groups.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group (Horseback riding simulator+Routine physiotherapy)
Horseback riding simulator (HRS) will be applied in addition to routine Physiotherapy and Rehabilitation. This group will receive 20 minutes of routine physiotherapy training and 20 minutes of HRS application in addition to 2 sessions per week for 8 weeks.
Horseback riding simulator
Horseback riding simulator (HRS) will be applied in addition to routine Physiotherapy and Rehabilitation.
Routine Physiotherapy and Rehabilitation
Routine Physiotherapy and Rehabilitation within a spesific programme
Control group (Routine physiotherapy)
Routine physiotherapy training will be applied within a specific programme for 40 minutes in 2 sessions per week for 8 weeks.
Routine Physiotherapy and Rehabilitation
Routine Physiotherapy and Rehabilitation within a spesific programme
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Horseback riding simulator
Horseback riding simulator (HRS) will be applied in addition to routine Physiotherapy and Rehabilitation.
Routine Physiotherapy and Rehabilitation
Routine Physiotherapy and Rehabilitation within a spesific programme
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Voluntary participation
* Age between 5-17 years,
* GMFCS Level I-II-III
* MACS Level I-II-III
* Modified Asworth Scale (MAS) Level 1-2-3
* Have the ability to sit with support
Exclusion Criteria
* Severe distractibility problems and inability to follow task instructions,
* Not voluntary to participate in the research,
* Individuals with CP who have had hip or spine surgery in the last 6 months
* Individuals with CP who have undergone Botox in the last 6 months
5 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hasan Kalyoncu University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yalcın KARABULUT
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yalçın Karabulut
Role: PRINCIPAL_INVESTIGATOR
Hasan Kalyoncu University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gaziantep
Gaziantep, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HKU-FTR-YK-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.